| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | chromatin | SOX7 SIN3B DFFB RARA RARB VPS72 PIAS3 CENPC RRP1B SETD5 RBL2 ICE2 SOX17 DDX23 HAT1 HSFY1 CREB3L3 TAF7 KAT6B TASOR | 1.18e-06 | 1480 | 84 | 20 | GO:0000785 |
| Domain | Nop52 | 1.90e-05 | 2 | 82 | 2 | IPR010301 | |
| Domain | Nop52 | 1.90e-05 | 2 | 82 | 2 | PF05997 | |
| Domain | Sox7/17/18_central | 5.70e-05 | 3 | 82 | 2 | IPR033392 | |
| Domain | Sox17_18_mid | 5.70e-05 | 3 | 82 | 2 | PF12067 | |
| Domain | Sox_C | 5.70e-05 | 3 | 82 | 2 | IPR021934 | |
| Domain | SOX_C | 5.70e-05 | 3 | 82 | 2 | PS51516 | |
| Domain | Retinoic_acid_rcpt | 1.14e-04 | 4 | 82 | 2 | IPR003078 | |
| Domain | ubiquitin | 1.15e-03 | 47 | 82 | 3 | PF00240 | |
| Domain | UBIQUITIN_2 | 1.72e-03 | 54 | 82 | 3 | PS50053 | |
| Domain | Ubiquitin_dom | 2.12e-03 | 58 | 82 | 3 | IPR000626 | |
| Domain | PHD | 4.39e-03 | 75 | 82 | 3 | PF00628 | |
| Domain | Znf_PHD-finger | 5.07e-03 | 79 | 82 | 3 | IPR019787 | |
| Pubmed | LIMK1 RARB VPS72 PIAS3 SACS RBL2 SIPA1L1 LRSAM1 SESN3 KIFC3 SMURF2 ADAM22 MTUS2 DYNC1H1 RPL13 RNF111 | 7.84e-08 | 1285 | 85 | 16 | 35914814 | |
| Pubmed | 2.29e-06 | 11 | 85 | 3 | 21146513 | ||
| Pubmed | Congenital diaphragmatic hernia: comparison of animal models and relevance to the human situation. | 3.05e-06 | 12 | 85 | 3 | 19325248 | |
| Pubmed | Mapping of the mouse Rar loci encoding retinoic acid receptors RAR alpha, RAR beta and RAR gamma. | 3.05e-06 | 12 | 85 | 3 | 8251184 | |
| Pubmed | SIN3B INTS6 C1orf115 VPS72 CENPC PDGFRA RBL2 CLVS2 ICE2 KMT2A CCL7 RPL13 BAP1 RPL18 | 3.91e-06 | 1327 | 85 | 14 | 32694731 | |
| Pubmed | Oct4 cell-autonomously promotes primitive endoderm development in the mouse blastocyst. | 3.96e-06 | 13 | 85 | 3 | 23747191 | |
| Pubmed | 4.61e-06 | 655 | 85 | 10 | 35819319 | ||
| Pubmed | 5.03e-06 | 14 | 85 | 3 | 21923909 | ||
| Pubmed | Recurrent RARB Translocations in Acute Promyelocytic Leukemia Lacking RARA Translocation. | 5.90e-06 | 2 | 85 | 2 | 29921692 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 16192283 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 1330302 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 18682240 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 24833708 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 22468089 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 7644503 | ||
| Pubmed | The PIAS3-Smurf2 sumoylation pathway suppresses breast cancer organoid invasiveness. | 5.90e-06 | 2 | 85 | 2 | 28423498 | |
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 9168777 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 1334013 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 15159591 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 30601638 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 27306217 | ||
| Pubmed | 5.90e-06 | 2 | 85 | 2 | 12009305 | ||
| Pubmed | 1.56e-05 | 20 | 85 | 3 | 25340657 | ||
| Pubmed | 1.66e-05 | 601 | 85 | 9 | 33658012 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11959842 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7607068 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7607067 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11172439 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8383767 | ||
| Pubmed | Retinoic acid receptor gamma: specific immunodetection and phosphorylation. | 1.77e-05 | 3 | 85 | 2 | 1655807 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19898560 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9659935 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 19328208 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 11245412 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 23969901 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 10100049 | ||
| Pubmed | Retinoic acid receptor-beta: immunodetection and phosphorylation on tyrosine residues. | 1.77e-05 | 3 | 85 | 2 | 1283441 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 36446525 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15528208 | ||
| Pubmed | Chromosomal assignment of retinoic acid receptor (RAR) genes in the human, mouse, and rat genomes. | 1.77e-05 | 3 | 85 | 2 | 1655630 | |
| Pubmed | Immunolocalization of retinoic acid receptors in rat, mouse and human ovary and uterus. | 1.77e-05 | 3 | 85 | 2 | 8136307 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8027572 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 2544807 | ||
| Pubmed | [Genetic expression and morphogenesis of the skin in vertebrates]. | 1.77e-05 | 3 | 85 | 2 | 8099268 | |
| Pubmed | Characterization of retinoic acid receptor-deficient keratinocytes. | 1.77e-05 | 3 | 85 | 2 | 10748128 | |
| Pubmed | FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N6-Methyladenosine RNA Demethylase. | 1.77e-05 | 3 | 85 | 2 | 28017614 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 2737701 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 29848550 | ||
| Pubmed | Expandable endodermal progenitors: new tools to explore endoderm and its derivatives. | 1.77e-05 | 3 | 85 | 2 | 18940723 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 35864174 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 17252005 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8626453 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 8388780 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 7910825 | ||
| Pubmed | Tissue-specific expression of retinoic acid receptor isoform transcripts in the mouse embryo. | 1.77e-05 | 3 | 85 | 2 | 10842077 | |
| Pubmed | Dll4 Blockade Promotes Angiogenesis in Nonhealing Wounds of Sox7-Deficient Mice. | 1.77e-05 | 3 | 85 | 2 | 33095124 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9699718 | ||
| Pubmed | Mammalian hexokinase 1: evolutionary conservation and structure to function analysis. | 1.77e-05 | 3 | 85 | 2 | 1783373 | |
| Pubmed | Association of retinoic acid receptor genes with meningomyelocele. | 1.77e-05 | 3 | 85 | 2 | 21254357 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 9852056 | ||
| Pubmed | Differential expression of retinoic acid receptors in normal and malignant esophageal tissues. | 1.77e-05 | 3 | 85 | 2 | 15255287 | |
| Pubmed | Heterochromatic gene repression of the retinoic acid pathway in acute myeloid leukemia. | 1.77e-05 | 3 | 85 | 2 | 17244680 | |
| Pubmed | The molecular and genetic dissection of the retinoid signalling pathway. | 1.77e-05 | 3 | 85 | 2 | 8276261 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 26549034 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 15831518 | ||
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 24357724 | ||
| Pubmed | Regulation of retinoic acid receptor alpha by protein kinase C in B16 mouse melanoma cells. | 1.77e-05 | 3 | 85 | 2 | 12000751 | |
| Pubmed | Specificity of retinoid receptor gene expression in mouse cervical epithelia. | 1.77e-05 | 3 | 85 | 2 | 8156902 | |
| Pubmed | 1.77e-05 | 3 | 85 | 2 | 25575120 | ||
| Pubmed | Immunohistochemical localization of the retinoic Acid receptors in human prostate. | 1.77e-05 | 3 | 85 | 2 | 12399530 | |
| Pubmed | 2.01e-05 | 65 | 85 | 4 | 32001436 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 24050824 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 8524212 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 19752193 | ||
| Pubmed | Stromal retinoic acid receptor beta promotes mammary gland tumorigenesis. | 3.53e-05 | 4 | 85 | 2 | 21187396 | |
| Pubmed | Biosynthesis and function of all-trans- and 9-cis-retinoic acid in parathyroid cells. | 3.53e-05 | 4 | 85 | 2 | 9005841 | |
| Pubmed | Redundant roles of Sox17 and Sox18 in early cardiovascular development of mouse embryos. | 3.53e-05 | 4 | 85 | 2 | 17610846 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 12093741 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 7967725 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 14691372 | ||
| Pubmed | The retinoic acid receptors RARalpha and RARgamma are required for inner ear development. | 3.53e-05 | 4 | 85 | 2 | 12464434 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9376317 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 28619820 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 2556642 | ||
| Pubmed | Retinoic acid signalling in the development of branchial arches. | 3.53e-05 | 4 | 85 | 2 | 15380252 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 10869350 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 19350571 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 7626396 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 17363914 | ||
| Pubmed | Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma. | 3.53e-05 | 4 | 85 | 2 | 22022577 | |
| Pubmed | Genetic factors for ischemic and hemorrhagic stroke in Japanese individuals. | 3.53e-05 | 4 | 85 | 2 | 18566305 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 9348290 | ||
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 15220343 | ||
| Pubmed | ECSASB2 mediates MLL degradation during hematopoietic differentiation. | 3.53e-05 | 4 | 85 | 2 | 22174154 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 16473829 | ||
| Pubmed | Sox7 promotes high-grade glioma by increasing VEGFR2-mediated vascular abnormality. | 3.53e-05 | 4 | 85 | 2 | 29444818 | |
| Pubmed | 3.53e-05 | 4 | 85 | 2 | 18845237 | ||
| Pubmed | Poly (ADP-ribose) glycohydrolase regulates retinoic acid receptor-mediated gene expression. | 3.53e-05 | 4 | 85 | 2 | 23102699 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DNAJC13 GZF1 PIAS3 CENPC RRP1B ZDHHC5 HAT1 KIRREL1 RRP1 RPL13 RNF111 RPL18 | 3.56e-05 | 1203 | 85 | 12 | 29180619 |
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | 3.65e-05 | 372 | 85 | 7 | 22939624 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 1.11e-03 | 17 | 53 | 2 | 486 | |
| GeneFamily | SRY-boxes | 1.40e-03 | 19 | 53 | 2 | 757 | |
| GeneFamily | PHD finger proteins | 2.33e-03 | 90 | 53 | 3 | 88 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 1.90e-06 | 193 | 85 | 6 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.14e-06 | 197 | 85 | 6 | 836dd8110d5689f944ad1d301def38c32278b5b5 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-Mes-Like-AT1_Progenitor|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.19e-06 | 125 | 85 | 5 | b1a12400f7070bdf09e87974c548a8b82e92b65e | |
| ToppCell | 368C-Myeloid-Macrophage-FABP4+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 8.94e-06 | 146 | 85 | 5 | 5b2608b56204dda9a773988f42ff00a9fa743a39 | |
| ToppCell | Ciliated_cells-A-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 151 | 85 | 5 | 9d03ce73af15ef40c592d19b36aff46bebc14c40 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 154 | 85 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.16e-05 | 154 | 85 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 155 | 85 | 5 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.19e-05 | 155 | 85 | 5 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.57e-05 | 164 | 85 | 5 | e4d4c59aebe5cacd4ecdb907facd044dc82a831d | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-05 | 165 | 85 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.62e-05 | 165 | 85 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | VE-CD4-proli_CD4|VE / Condition, Cell_class and T cell subcluster | 2.33e-05 | 178 | 85 | 5 | f0a0cbf73e03f1b29f0be6598517c8a1da41c8dc | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 181 | 85 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.52e-05 | 181 | 85 | 5 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.59e-05 | 182 | 85 | 5 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | (4)_Endothelial_cells-(40)_EC-arterial|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.73e-05 | 184 | 85 | 5 | 7e1a2971321ddcfa00d78d3e3ba7960e532f9392 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.73e-05 | 184 | 85 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | COPD-Epithelial-Ciliated|COPD / Disease state, Lineage and Cell class | 2.95e-05 | 187 | 85 | 5 | f0fd0792f6926f705d175f6e6fd480f12c7a3bd4 | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease state, Lineage and Cell class | 3.10e-05 | 189 | 85 | 5 | c007fccd08728db3ea99af9da91d67b9b16dabb3 | |
| ToppCell | COPD-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.10e-05 | 189 | 85 | 5 | 3e77883db34722b9ce0a03ea74caefc92dc7feff | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | f50b9814a1beac67dc042a8c27dfd085ceeda3a6 | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | a22a510b4a257eb0eaf09c7ae7978d3d2f07a58c | |
| ToppCell | droplet-Lung-21m-Endothelial-lymphatic_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 190 | 85 | 5 | 57c136bf6d7feafb4a220877bed0cc8fdf314db2 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-05 | 191 | 85 | 5 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-05 | 191 | 85 | 5 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.26e-05 | 191 | 85 | 5 | fda432a7f79664e8ffd5d03c1c69ec43bbac994b | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.26e-05 | 191 | 85 | 5 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | (210)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.34e-05 | 192 | 85 | 5 | 08dc0c019c594da7b9944db8fd706aa7780e6ae9 | |
| ToppCell | (21)_NKT_cell|World / immune cells in Peripheral Blood (logTPM normalization) | 3.34e-05 | 192 | 85 | 5 | b0a573ddde2978485a857b8261ee1ee5ef68ecef | |
| ToppCell | IPF-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.34e-05 | 192 | 85 | 5 | d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11 | |
| ToppCell | COPD-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.34e-05 | 192 | 85 | 5 | eab1105cd1a98cfcd3d74dc5c9b89e1799bba59e | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 3.34e-05 | 192 | 85 | 5 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | COVID-19_Convalescent-CD4+_T_naive|COVID-19_Convalescent / Disease condition and Cell class | 3.42e-05 | 193 | 85 | 5 | 346caaf288217acaf232060629ce964a07f63432 | |
| ToppCell | Control-Epithelial-Ciliated|Epithelial / Disease state, Lineage and Cell class | 3.42e-05 | 193 | 85 | 5 | 0e37d454f3735edd936ee9a5f5f516ac3aad400e | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 3.42e-05 | 193 | 85 | 5 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive_helper_T_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.42e-05 | 193 | 85 | 5 | 792315f409a57fa6a8a88c850060b1e089e062ea | |
| ToppCell | Control-Epithelial-Ciliated|World / Disease state, Lineage and Cell class | 3.51e-05 | 194 | 85 | 5 | 958e648138676d46698090b4046cb484083ae449 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.60e-05 | 195 | 85 | 5 | 4e114f6399863406bd87220dea7fb7dfd08824bd | |
| ToppCell | IPF-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 3.60e-05 | 195 | 85 | 5 | 21dbdc803c6947024dc2416e9e21c2ef0af9bc31 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.60e-05 | 195 | 85 | 5 | 5562665dd3beb70e2358aa32611a337bef5731c1 | |
| ToppCell | IPF-Epithelial|IPF / Disease state, Lineage and Cell class | 3.69e-05 | 196 | 85 | 5 | 87d9881cfec461a5d89b688a83749b618c519485 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.78e-05 | 197 | 85 | 5 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.78e-05 | 197 | 85 | 5 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 3.78e-05 | 197 | 85 | 5 | 63d0f06e150e7eb800ecb70e97b9d12a01c84e37 | |
| ToppCell | COVID_vent-Lymphocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.87e-05 | 198 | 85 | 5 | ee80f647317377081b4bd194ee2801f556b3a53b | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.87e-05 | 198 | 85 | 5 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | Caecum-T_cell-Tcm|T_cell / Region, Cell class and subclass | 3.87e-05 | 198 | 85 | 5 | f889ee80c641540fd8db9eaefcd16aa51ddb2c01 | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial|LPS_only / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | e035380578c01b0243bfef29ca9b50cc17cce771 | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / Treatment groups by lineage, cell group, cell type | 3.87e-05 | 198 | 85 | 5 | ba090210392e001a3f7bdf09371b3f0e0c8c7ef3 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 2498237b9e895ca4826a3378d9d40989968df72b | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_ciliated-Ciliated|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.96e-05 | 199 | 85 | 5 | 542ec45c931b40738df1f3777b00c83be33a514a | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.96e-05 | 199 | 85 | 5 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|356C / Donor, Lineage, Cell class and subclass (all cells) | 8.52e-05 | 121 | 85 | 4 | 4ec70ad316942d9ade7bbdbf0e117e7c52b59d90 | |
| ToppCell | Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.19e-04 | 132 | 85 | 4 | 06e7337de35bd7120655a22b6020604ad004c4e1 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_STALK-Flt1_2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 133 | 85 | 4 | 29b0c2c682c6b97823e7d8d8ba1f5114044b30ba | |
| ToppCell | Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 1.23e-04 | 133 | 85 | 4 | bc29a2faa151b0e48c1c7e3f016cccc49f9a15eb | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 137 | 85 | 4 | 306b11b3b9e5fd562d845fb5eaa4ac982864efce | |
| ToppCell | Striatum-Endothelial-ENDOTHELIAL_STALK|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.38e-04 | 137 | 85 | 4 | d37f425b13bc046baa1f8619b98a16b936f88ff6 | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.67e-04 | 144 | 85 | 4 | 1c118b22c2ff3a526a5207d6c9d772636ee065fd | |
| ToppCell | 15-Trachea-Immune-Immune|Trachea / Age, Tissue, Lineage and Cell class | 1.76e-04 | 146 | 85 | 4 | ca722a89c6601e78f253d9484d01931f26161820 | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 148 | 85 | 4 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-04 | 148 | 85 | 4 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | Globus_pallidus-Endothelial-ENDOTHELIAL_STALK|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.90e-04 | 149 | 85 | 4 | d9c47f523c75ddcd6131e45d2ffc24b970932cae | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.90e-04 | 149 | 85 | 4 | 14d2e8cab97108d8fa94e540c1957b73ed32dc73 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.90e-04 | 149 | 85 | 4 | 54c9c6282f5f5de43dfaf2972fab3e3dcf9838a3 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.95e-04 | 150 | 85 | 4 | b6f1fc62d08199fed6156c7cd32f66d9926531b5 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_mucous|COVID-19 / group, cell type (main and fine annotations) | 2.00e-04 | 151 | 85 | 4 | 8216462e723fec2797387929dde095370947e10a | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 154 | 85 | 4 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-04 | 154 | 85 | 4 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 62 | 85 | 3 | dd2e222d454fb78fed8b37901cbf04c0080ed010 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Syt6-Excitatory_Neuron.Slc17a7.Syt6-Nnat_(Neuron.Slc17a7.Syt6-Nnat)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.27e-04 | 62 | 85 | 3 | 6a3f990e8d59392ad909634a239b3ab4f13d8855 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 158 | 85 | 4 | f296ca24fdedc33f1d24b79e7660763114ce7fa3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 158 | 85 | 4 | 8c7108f2c40d97a317762ba0b8eca76542b2ebaf | |
| ToppCell | COVID-CD4-CD4_Treg|COVID / Condition, Cell_class and T cell subcluster | 2.43e-04 | 159 | 85 | 4 | 037cd97c41eb2f91fd3f69bbb3ffdfd6c0158410 | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.49e-04 | 160 | 85 | 4 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-04 | 161 | 85 | 4 | 9f02b94e29e60d50e92eaa748ebf0c36d3671bb3 | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-mature_alpha-beta_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 162 | 85 | 4 | b5b2cdbcc5bbfab52cc7d8a5504d34bb2e73771a | |
| ToppCell | facs-Marrow-T-cells-24m-Lymphocytic-BM_CD8_+_CD4_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.61e-04 | 162 | 85 | 4 | 4f9cf67b4b00b1cf78eeb9be1c701d535021a61d | |
| ToppCell | Ciliated_cells-B-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 2.74e-04 | 164 | 85 | 4 | fd30c55d0d75ef8b9396435d836187168095152b | |
| ToppCell | LPS_only-Epithelial_airway|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.74e-04 | 164 | 85 | 4 | 56e6934e6c7503a300d7be06762d45a1d6f1ae0f | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 165 | 85 | 4 | 0c80abf13409767825ef8a507b498afafa7e89c5 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-04 | 165 | 85 | 4 | cced77f2d74b07010307d7f4788b8cf3fdaeb91a | |
| ToppCell | 10x3'2.3-week_17-19-Hematopoietic-HSC/MPP_and_pro-MPP_myeloid|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.80e-04 | 165 | 85 | 4 | dc70e050465d1f05bb4115356dc978aa581149b5 | |
| ToppCell | facs-Lung-Endomucin-24m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.93e-04 | 167 | 85 | 4 | 4520ee71e2b119c1dfa0e342fe57eda5f3598650 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.00e-04 | 168 | 85 | 4 | 9a8709d34865cfa668d8f3335dc34fc86fc32482 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 168 | 85 | 4 | 94cded2e953c0970bf2f3dbe0ce46bd77a5ed8c7 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.00e-04 | 168 | 85 | 4 | 2fb2d916eb5000a637240d38e47a9b4f61f9f83f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 169 | 85 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.07e-04 | 169 | 85 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.07e-04 | 169 | 85 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Proliferating-cycling_ventral_progenitors|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-04 | 170 | 85 | 4 | 73601c873b177d5d134618d8e228c51381119f7d | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.21e-04 | 171 | 85 | 4 | 61d622153b91702ef21b0efc7b9581e592b7ccea | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-10|TCGA-Brain / Sample_Type by Project: Shred V9 | 3.21e-04 | 171 | 85 | 4 | 74be8d3bf6b99e2d734635a8b1a7c41e8c596959 | |
| ToppCell | systemic_lupus_erythematosus-treated-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.21e-04 | 171 | 85 | 4 | 09b3fa120f63c411f8a0dd6bd230a9720ce83fb1 | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.28e-04 | 172 | 85 | 4 | ba99688e9f46671deccf824b1e77c6db0742d7df | |
| ToppCell | E12.5-Endothelial-proliferative_endothelial_cell|E12.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.28e-04 | 172 | 85 | 4 | 2136170f6e1204734cec7dbf7b32e7d5179b92b5 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.28e-04 | 172 | 85 | 4 | 73e9b29b1c6b8b016b495a0d20336d0c0761e5e2 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 66f37c1437705734b20601656fa4aa1d92ca30be | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-04 | 173 | 85 | 4 | 649b08a409095592cccf31883be69c754411280d | |
| Drug | Monobenzone [103-16-2]; Up 200; 20uM; MCF7; HT_HG-U133A | 7.17e-06 | 197 | 82 | 7 | 5312_UP | |
| Drug | UVI 3003 | 7.28e-06 | 11 | 82 | 3 | ctd:C525131 | |
| Drug | Cefaclor [70356-03-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 7.41e-06 | 198 | 82 | 7 | 4967_DN | |
| Drug | Ro 8-8717 | 1.28e-05 | 2 | 82 | 2 | CID006438148 | |
| Drug | Tamibarotene | 1.28e-05 | 2 | 82 | 2 | DB04942 | |
| Drug | 4-(1H-imidazol-1-yl)retinoic acid | 3.53e-05 | 18 | 82 | 3 | ctd:C496751 | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; HL60; HT_HG-U133A | 3.96e-05 | 174 | 82 | 6 | 2452_UP | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 6.27e-05 | 189 | 82 | 6 | 2695_UP | |
| Drug | Fenoterol hydrobromide [1944-12-3]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 7.04e-05 | 193 | 82 | 6 | 5432_DN | |
| Drug | Bromocryptine mesylate [22260-51-1]; Up 200; 5.4uM; MCF7; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 5665_UP | |
| Drug | Hemicholinium bromide [312-45-8]; Down 200; 7uM; PC3; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 6739_DN | |
| Drug | radicicol, diheterospora chlamydosporia; Down 200; 0.1uM; MCF7; HT_HG-U133A | 7.45e-05 | 195 | 82 | 6 | 5579_DN | |
| Drug | AC1L32JQ | 7.57e-05 | 23 | 82 | 3 | CID000133319 | |
| Drug | sporostatin | 7.65e-05 | 4 | 82 | 2 | CID006444393 | |
| Drug | SRI 5898-21 | 7.65e-05 | 4 | 82 | 2 | CID006439757 | |
| Drug | Tazarotene | 7.65e-05 | 4 | 82 | 2 | DB00799 | |
| Drug | Nomegestrol acetate [58652-20-3]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 7.67e-05 | 196 | 82 | 6 | 5461_DN | |
| Drug | Sulpiride [15676-16-1]; Down 200; 11.8uM; HL60; HG-U133A | 7.67e-05 | 196 | 82 | 6 | 1967_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Down 200; 13.6uM; HL60; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 2141_DN | |
| Drug | Quipazine dimaleate salt [4774-24-7]; Down 200; 9uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 2782_DN | |
| Drug | Thioridazine hydrochloride [130-61-0]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 4164_DN | |
| Drug | Sulfamethizole [144-82-1]; Down 200; 14.8uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 6099_DN | |
| Drug | Alclometasone dipropionate [667634-13-2]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 7.89e-05 | 197 | 82 | 6 | 6094_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 8.11e-05 | 198 | 82 | 6 | 3843_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 3966_UP | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; HL60; HT_HG-U133A | 8.34e-05 | 199 | 82 | 6 | 2579_UP | |
| Drug | Tobramycin [32986-56-4]; Up 200; 8.6uM; HL60; HT_HG-U133A | 8.57e-05 | 200 | 82 | 6 | 2481_UP | |
| Drug | AC1L45LU | 9.82e-05 | 205 | 82 | 6 | CID000151069 | |
| Disease | Neuralgia-Neuritis, Sciatic Nerve | 4.90e-05 | 4 | 85 | 2 | C0751924 | |
| Disease | Sciatic Nerve Palsy | 4.90e-05 | 4 | 85 | 2 | C0751925 | |
| Disease | Lesion of Sciatic Nerve | 4.90e-05 | 4 | 85 | 2 | C0154748 | |
| Disease | Sciatic Neuritis | 4.90e-05 | 4 | 85 | 2 | C0242013 | |
| Disease | Sciatic Neuropathy | 4.90e-05 | 4 | 85 | 2 | C0149940 | |
| Disease | Head and Neck Neoplasms | 1.18e-04 | 33 | 85 | 3 | C0018671 | |
| Disease | Hereditary Diffuse Gastric Cancer | 2.06e-04 | 293 | 85 | 6 | C1708349 | |
| Disease | Stomach Neoplasms | 2.22e-04 | 297 | 85 | 6 | C0038356 | |
| Disease | pantothenate measurement | 2.27e-04 | 8 | 85 | 2 | EFO_0021034 | |
| Disease | Cornelia De Lange Syndrome | 2.27e-04 | 8 | 85 | 2 | C0270972 | |
| Disease | Malignant neoplasm of stomach | 2.34e-04 | 300 | 85 | 6 | C0024623 | |
| Disease | Malignant Head and Neck Neoplasm | 2.81e-04 | 44 | 85 | 3 | C0278996 | |
| Disease | C-C motif chemokine 21 measurement | 3.64e-04 | 10 | 85 | 2 | EFO_0008048 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 5.31e-04 | 12 | 85 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | C-C motif chemokine 19 measurement | 7.30e-04 | 14 | 85 | 2 | EFO_0008047 | |
| Disease | Precursor B-cell lymphoblastic leukemia | 1.66e-03 | 21 | 85 | 2 | C1292769 | |
| Disease | Nasopharyngeal carcinoma | 1.82e-03 | 22 | 85 | 2 | C2931822 | |
| Disease | Intrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C0345905 | |
| Disease | Head Neoplasms | 2.17e-03 | 24 | 85 | 2 | C0018675 | |
| Disease | Upper Aerodigestive Tract Neoplasms | 2.17e-03 | 24 | 85 | 2 | C0887900 | |
| Disease | Extrahepatic Cholangiocarcinoma | 2.17e-03 | 24 | 85 | 2 | C3805278 | |
| Disease | Cancer of Head | 2.17e-03 | 24 | 85 | 2 | C0751177 | |
| Disease | creatinine measurement | 2.26e-03 | 995 | 85 | 9 | EFO_0004518 | |
| Disease | Neck Neoplasms | 2.36e-03 | 25 | 85 | 2 | C0027533 | |
| Disease | Cancer of Neck | 2.36e-03 | 25 | 85 | 2 | C0746787 | |
| Disease | Antiglaucoma preparations and miotics use measurement | 2.55e-03 | 26 | 85 | 2 | EFO_0009944 | |
| Disease | Cholangiocarcinoma | 2.55e-03 | 26 | 85 | 2 | C0206698 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YEKFKETILRIKRRR | 401 | Q5W0A0 | |
| FGILIKRRQQKIRKY | 671 | P04626 | |
| VRLYLPKRKSETRRR | 91 | Q6P093 | |
| SQRKIPAKVVRSYRK | 36 | O00585 | |
| LYKLFKRRPRISKQK | 1306 | Q8NDM7 | |
| RRKNKAVFRPKIRIN | 366 | Q96N23 | |
| LTKYEERVLKKIRRK | 236 | Q68CJ9 | |
| RLRVRKAIGKYRIKL | 601 | Q96Q27 | |
| VFVEIPKKKYTRRLR | 231 | Q9H116 | |
| ELTKIYRRKRKPAVD | 1916 | O95477 | |
| LKPRPKRSKRQLRRY | 216 | Q9P0K1 | |
| LYDNVKVKKLRLRRG | 606 | Q8IYW2 | |
| KQRKPDRRKRSRPYK | 711 | Q92560 | |
| KYNKPRAKSKPERRR | 416 | Q9Y5C1 | |
| QAKPRYRRLILKTQI | 81 | Q8NC38 | |
| IYKPQTRLKRKQPVR | 321 | O76075 | |
| LRKKSRREYLAKRER | 226 | O60231 | |
| PSEQPRKRYRRKLKK | 86 | Q9H7X2 | |
| KPKHVRPKIITYIRR | 636 | Q5JR59 | |
| LEALKVYVRKRRPSR | 356 | P10276 | |
| LEALKIYIRKRRPSK | 356 | P10826 | |
| RKPGRKYERIFTLLK | 821 | Q9UL03 | |
| PFVLKKKRGRKRRRI | 1126 | Q8WYB5 | |
| VYRSVLIKGKRKRRN | 926 | Q08999 | |
| QEIRYRSKLKLIRAK | 371 | P16234 | |
| RRKFKYRGKDVSLRR | 11 | A9QM74 | |
| SPDKLRKVIYRRKKV | 61 | Q9H079 | |
| KRGYPQLLVRVKRRI | 181 | Q96LI6 | |
| RKRKPSEEARKRLEY | 6 | Q6UWE0 | |
| IQRRLPRERKIKYSK | 541 | Q8IWD5 | |
| KPERRRLKTTRLKEY | 291 | O43293 | |
| YFVCRKPKIRERRLQ | 401 | P0C6S8 | |
| KERYLGGIKKRRRTR | 251 | Q9BUQ8 | |
| IRKVKEKIRRTRGYS | 376 | Q15646 | |
| YLRQKLRAELKPKTR | 1751 | Q4G0P3 | |
| RSKKRKKIRRQFPVY | 756 | Q659A1 | |
| KRRLISPYKKKQRDL | 356 | O14929 | |
| YEVRRGKKRVKRLSQ | 491 | Q9ULE3 | |
| NVRRTKRTRLKPLEY | 736 | Q03188 | |
| RYLVPLQSKNKLRKR | 196 | Q6P4F1 | |
| RLEKKRRKAQRLPYY | 1456 | Q9P0X4 | |
| KPVVLRKRRQRIKIE | 741 | O75165 | |
| PRKQRRKIYHRRLRK | 26 | O94769 | |
| TKEKIYQPLRRSKRR | 41 | Q8IXH8 | |
| KYRRDIRPEVKLTPR | 686 | Q13634 | |
| KIRNTKYPIQRALRL | 366 | Q14204 | |
| YRRRKGSRKDVTLRK | 521 | Q96J84 | |
| VSNRKRKRKVFSPIR | 731 | Q03164 | |
| KKIPKQRLESYRRTT | 41 | P80098 | |
| KSQPVRKPRYVRRER | 346 | Q96HA4 | |
| PESERKKIIRRLYLK | 4321 | Q9NZJ4 | |
| RLKEYRSKLILFPRK | 116 | P26373 | |
| NTLRRTRKKVTKPYV | 26 | Q5TDP6 | |
| LRKRLSQRLKVPKER | 56 | Q504T8 | |
| ITLPLKNVRKRRFRK | 136 | Q15545 | |
| KYRPRRRKQVKRLKR | 136 | Q9H6I2 | |
| NYKYRPRRKKQAKRL | 111 | Q9BT81 | |
| KGIRDRAVKKLRQYI | 21 | Q14684 | |
| LLRKYRRELQLRKKC | 421 | Q9BVG8 | |
| RGRRKSRFALYKRPK | 36 | Q9HAT8 | |
| RNISERRTYRKIIPK | 1036 | Q8NDX1 | |
| HRYLRKILIRKNLPK | 526 | Q6AI14 | |
| NLRLFKEREKPLKRR | 271 | O43166 | |
| PQRKKVSLLEYRKRK | 1061 | Q9C0A6 | |
| KPVFLQRNLKKFRRR | 1011 | O75182 | |
| TPSQNRKRLYKVIRK | 316 | P56182 | |
| RKRLYKVIRKLQDLA | 321 | P56182 | |
| RRIAQKIIREPRKKR | 271 | Q9BVR0 | |
| VRRSFQIPRKSREKK | 96 | Q9UK61 | |
| RRYARKIEPIRRKGN | 226 | Q6P4Q7 | |
| PRTELKKKLFKRRRV | 11 | E9PRG8 | |
| YTVIRPFLKEKTRKR | 211 | Q5SYC1 | |
| KIKELYRRRFPRKTL | 56 | Q9Y6X2 | |
| PRYKRDLVQKLKILR | 366 | Q9HAU4 | |
| RKVRRKEPKSQDIYL | 11 | Q07020 | |
| TRYPTVKQIRKLRQL | 91 | Q9UNW1 | |
| RKKREVLARRKYALL | 236 | Q6ZNA4 | |
| RKVLRKDKRIRVSQP | 21 | P58005 | |
| RIRLPRKATKTKKNY | 1011 | Q9BX26 | |
| QKRRVYRRKRSKFLL | 386 | Q5T6S3 | |
| IYKRNERIGKRVKAL | 301 | Q86V40 | |
| REAVKLKITKYLRRA | 96 | Q9Y6S9 | |
| RKKRRRSRLVLYPET | 91 | Q9NXH8 | |
| RYLGRPKKEKTIVIR | 251 | Q9C0B5 | |
| EEPRRKRRVVTKAYK | 76 | Q15906 | |
| RSLKKPDRKKRYTVV | 496 | P53667 |